Skip to main content
. 2021 Sep 17;8:734550. doi: 10.3389/fcvm.2021.734550

Table 1.

Non-coding RNAs regulating EndMT in atherosclerosis.

Non-coding RNAs Targets Regulation Models Year Reference
miR-449a AdipoR2 upregulation ApoE−/− diabetic mice
Human carotid atherosclerotic plaque
HUVECs
2019 (76)
miR-374b MAPK7 upregulation Human coronary arteries
Pigs
HUVECs
2019 (77)
miR-122 NPAS3 upregulation ApoE−/− mice
HAECs
HUVECs
2021 (78)
H19 TET1/TGFβR2/TSP1 upregulation H19 KO mice
Primary mouse pulmonary endothelial cells
HAECs
HUVECs
2010 (83)
MALAT1 Wnt/β-catein upregulation ApoE−/− mice
HUVECs
2019 (85)
LIC00657 miR-30c-5p/Wnt7b/β-catenin upregulation Atherosclerosis patients serum
HUVECs
2020 (86)
LncRNA ZFAS1 miR-150-5P/Notch3 upregulation ApoE−/− mice HUVECs 2021 (89)

List of non-coding RNAs regulating EndMT associated with atherosclerosis including miRNA and lncRNAs. AdipoR2, Adiponectin receptor 2; MAPK7, Mitogen-activated protein kinase 7; NPAS3, Neuronal PAS Domain Protein 3; TET1, Tet Methylcytosine Dioxygenase 1; TGFβR2, TGF-βreceptor 2; TSP1, Thrombospondin 1; MALAT1, Metastasis-associated lung adenocarcinoma transcript 1; HUVECs, Human umbilical vein endothelial cells; HAECs, Human Aortic Endothelial Cells.